Announcement on Approval by the US FDA of the Formulation Product Micafungin Sodium for Injection of the Wholly-owned Subsidiary
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment